Assembly Biosciences Inc expected to post a loss of $1.36 a share - Earnings Preview

Assembly Biosciences

04/08/2025 23:00

Assembly Biosciences Inc ASMB.OQ ASMB.O is expected to  show a fall in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025

The South San Francisco California-based  company is expected to report a 26.6% decrease in revenue to $6.262 million from $8.53 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Assembly Biosciences Inc is for a loss of $1.36 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Assembly Biosciences Inc is $31.00, about 40.6% above its last closing price of $18.40

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-1.60
-1.60
-1.17
Beat
26.9
Dec. 31 2025
-2.04
-1.57
Beat
23
Sep. 30 2024
-2.02
-2.02
-1.51
Beat
25.2​
Jun. 30 2024
-2.23
-2.23
-1.98
Beat
11.2
​​Mar. 31 2024
-3.23
-3.23
-1.66
Beat
48.6
Dec. 31 2023
-2.88
-2.15
Beat
25.3​
Sep. 30 2023
-2.76
-3.24
Missed
-17.4
Jun. 30 2023
-3.46
-3.48
-3.84
Missed
-10.3

This summary was machine generated August 4 at 22:00 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)